Skip to main content
Equibles

Rebecca Chambers

CFO

Veracyte, Inc. (VCYT)

Equibles does not estimate personal net worth.

Get an email with a short summary when Veracyte, Inc. publishes a filing, an earnings call transcript or a press release.

Get VCYT alerts

About Rebecca Chambers

Rebecca Chambers is recorded as CFO at Veracyte, Inc. (VCYT). The newest filing on record that lists Rebecca Chambers as CFO at Veracyte, Inc. (VCYT) is dated April 22, 2026. The proxy statement of Veracyte, Inc. reports total compensation of $2,875,554 for Rebecca Chambers in fiscal 2025, including a base salary of $550,000. Disclosed compensation is on record for 5 fiscal years. Rebecca Chambers has spoken on 21 earnings calls and 2 other investor events across 1 company, most recently for Veracyte, Inc. on August 11, 2026. Veracyte, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Veracyte, Inc. includes Marc Stapley (CEO and Board Member), Bonnie H. Anderson (Chairman), Christopher Hall (COO) and 7 others.

Rebecca Chambers on recent calls

“So our philosophy is that a well-run molecular diagnostic company should be able to sustain an adjusted EBITDA of around 25%. And at the same time, invest in long term growth drivers, right?”
CFO, Canaccord Genuity 46th Annual Growth Conference ·
“We delivered total revenue of $150.3 million in the second quarter, representing 15% year-over-year growth. Total volume increased to approximately 51,000 tests, up 13% compared to the same period in 2025.”
CFO, Veracyte Second Quarter 2026 Financial Results Webcast ·
“Well, we're in a very fortunate position in that we have incredibly strong gross margins and ASP as a result of the great work that the managed care team has done and the operations team has done.”
CFO, William Blair 46th Annual Growth Stock Conference ·
“The first quarter was a very strong start to the year and reflects the disciplined execution and scale we've built over the past several years. We delivered total revenue of $139.1 million, representing 21% year-over-year growth.”
CFO, Veracyte, Inc. Q1 FY2026 Earnings Call ·
“Q4 was another exceptional quarter with $140.6 million in revenue, an increase of 19% over the prior year period.”
CFO, Veracyte, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Veracyte, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Veracyte, Inc. (VCYT) $550,000 $2,875,554
2024 Veracyte, Inc. (VCYT) $530,400 $3,645,346
2023 Veracyte, Inc. (VCYT) $510,000 $2,778,584
2022 Veracyte, Inc. (VCYT) $463,500 $3,322,756
2021 Veracyte, Inc. (VCYT) $204,807 $3,382,037

Recent activity

Show 11 earlier activities